Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2005
03/30/2005CN1600339A A plaster for curing rheumatoid arthritis
03/30/2005CN1600337A A plaster for curing hyperosteogeny
03/30/2005CN1600331A Combination of Chinese traditional medicine possessing function of activating the channels and expelling rheumatism
03/30/2005CN1600304A Application of extractive of ussurian grape on curing inflammatory disease
03/30/2005CN1194978C Phosphinous and phosphonic acid derivs. used as medicaments
03/30/2005CN1194976C Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
03/30/2005CN1194751C Bone-strengthening medicine, method for preparing tablet, capsule and oral liquor using same
03/30/2005CN1194743C Chinese medicinal composition for treating atrophic arthritis, preparing method and quality controlling method thereof
03/30/2005CN1194731C Orally taken fracture setting Chinese medicine
03/30/2005CN1194726C Capsule for treating cervical spondylopathy and its preparing process
03/30/2005CN1194718C Plaster for treating pains of neck, shoulder, waist and leg and prepn, process
03/30/2005CN1194709C Kidney invigorating and bone strengthening medicine and its preparing method
03/29/2005US6872744 Analgesics
03/29/2005US6872743 Antiinflammatory agents; sepsis shock; antiarthritic agents
03/29/2005US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
03/29/2005US6872735 LFA-1 antagonist compounds
03/29/2005US6872730 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
03/29/2005US6872725 Crystallized p38 kinase inhibitors for treatment of rheumatoid arthritis
03/29/2005US6872721 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione
03/29/2005US6872719 Antiinflammatory agents; autoimmune disease
03/29/2005US6872714 Methods to modulate conditions mediated by the CXCR4 receptor
03/29/2005US6872702 Cyclic peptide; antitumor agents; antiinflammatory agents; tissue remodeling
03/29/2005CA2335186C Pyrrolo[2,3-d]pyrimidine compounds
03/24/2005WO2005025611A1 Inhibitors of pace4 for the treatment of arthritis
03/24/2005WO2005025605A1 Remedy and therapeutic method for periodontal diseases and pulpal diseases
03/24/2005WO2005025603A2 Methods of using wisp antagonists
03/24/2005WO2005025598A1 Antibacterial drug for propionibacterium acnes
03/24/2005WO2005025571A1 A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug.
03/24/2005WO2005025569A1 Use of known active ingredients as radical scavengers
03/24/2005WO2005025504A2 Modulators of calcitonin and amylin activity
03/24/2005WO2005009331A3 Use of a cosmetic or pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins
03/24/2005WO2004112808A3 Therapeutic use of lipids extracted from mother of pearl
03/24/2005WO2004098618A3 Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
03/24/2005WO2004092144A3 Quinazoline compounds useful as p38 kinase inhibitors
03/24/2005WO2004017948A8 Use of lck inhibitor for treatment of immunologic diseases
03/24/2005WO2003104407A3 T cell receptor cdr3 sequences and methods for detection
03/24/2005WO2003103478A3 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
03/24/2005WO2003059291A3 Treatment of bone disorders with skeletal anabolic drugs
03/24/2005WO2002092759A9 Molecules for disease detection and treatment
03/24/2005US20050065327 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders
03/24/2005US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders
03/24/2005US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
03/24/2005US20050065180 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a growth hormone secretagogue
03/24/2005US20050065155 Autoimmune disease ; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents
03/24/2005US20050065148 Dipeptidyl peptidase inhibitors
03/24/2005US20050065134 2-aklylidene-19-nor-vitamin D derivatives for the treatment of anorexia or low bone mass in females exhibiting aggressive athletic behavior
03/24/2005US20050065133 Synergistic mixture; bone disorders; osteoporosis ; anticancer agents; obesity
03/24/2005US20050065132 Bone disorders
03/24/2005US20050065131 Enhancing bone mass
03/24/2005US20050065130 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a cyclooxgenase-2 inhibitor
03/24/2005US20050065127 Bone disorders; anticarcinogenic agents
03/24/2005US20050065126 Synergistic mixture; osteoporosis therapy; bone disorders; anticancer agents; obesity
03/24/2005US20050065125 2-alkylidene-19-nor-vitamin D derivatives for the treatment of osteopenia or male osteoporosis
03/24/2005US20050065117 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate
03/24/2005US20050065116 Thiazolopyrimidines useful as TNFalpha inhibitors
03/24/2005US20050065112 Antiproliferative agents; low toxicity; psoriasis; antitumor agents; rheumatic arthritis; gastrointestinal disorders; antiinflamamtory agents
03/24/2005US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases
03/24/2005US20050065088 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone
03/24/2005US20050065087 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bone morphogenetic protein
03/24/2005US20050065068 Methods and compositions for reducing serum phosphate levels
03/24/2005US20050064586 Somatic cell derived embryonic stem cells and its differentiated cells
03/24/2005US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases
03/24/2005US20050064539 Glycoprotein and process for producing the same
03/24/2005US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders
03/24/2005US20050064048 Compositions comprising organic extracts of geum japonicum thunb var. and the use thereof
03/24/2005US20050064044 Administering Glycogen synthase kinase 3 (GSK-3) inhibitors such as lithium chloride to treat osteoporosis for example; drug screening
03/24/2005US20050064018 Use of vitamin D compounds
03/24/2005US20050063992 administering to a patient 2-methylene-19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 and an estrogen, or a salt or prodrug for treating senile osteoporosis, postmenopausal osteoporosis, bone fracture, bone graft, breast cancer, prostate cancer, obesity, osteopenia, muscle damage or sarcopenia
03/24/2005US20050063969 Assay
03/24/2005US20050063959 By transfection with an an osteo-/chondro-inducible transcription factor gene such as Cbfa1, Dlx-5, Bapx1, Msx2, Scleraxis, or Sox9, and allowing the cells to differentiate and proliferate on a scaffold; implants
03/24/2005CA2539300A1 Inhibitors of pace4 for the treatment of arthritis
03/24/2005CA2538910A1 Use of known active ingredients as radical scavengers
03/24/2005CA2538429A1 Antibacterial drug for propionibacterium acnes
03/24/2005CA2538416A1 A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug.
03/24/2005CA2536396A1 Methods of using wisp antagonists
03/23/2005EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor
03/23/2005EP1516881A2 Composition and method for modulating dendritic Cell-T cell interaction
03/23/2005EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto
03/23/2005EP1516624A1 Method of producing calcium gluconolactate, compositions, processes and uses of same
03/23/2005EP1516540A1 Use of vitamin D compounds
03/23/2005EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
03/23/2005EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
03/23/2005EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
03/23/2005EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
03/23/2005EP1515736A1 Compositions against inflammatory processes
03/23/2005EP1515728A2 Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema
03/23/2005EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
03/23/2005EP1515716A2 Indole derivatives having anti-angiogenetic activity
03/23/2005EP1515707A2 Method of treating atherosclerosis and other inflammatory diseases
03/23/2005EP1357937B1 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology
03/23/2005EP1114166B1 Method for down-regulating osteoprotegerin ligand activity
03/23/2005EP1032398B1 Treating postmenopausal women using ultra-low doses of estrogen
03/23/2005CN1599793A Chondrocyte precursors derived from human embryonic stem cells
03/23/2005CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
03/23/2005CN1599737A Ring fused pyrazole derivatives
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
03/23/2005CN1599627A Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
03/23/2005CN1599613A Combinations for the treatment of immunoinflammatory disorders
03/23/2005CN1599610A Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1, 4'bipiperidine as ccr5-antagonists for the treatment of aid